• Français
  • English
  • Français
  • English

Fiche de : Lionel MAURIZI

Département :
Nanosciences


Fonction :

CR CNRS



Localisation :

C408A

Tél. : +333 80 39 61 71
E-mail : lionel.maurizi@u-bourgogne.fr

Researchgate profile

With a chemical engineering background I started in 2010 a PhD in physical-chemistry on the syntheses and characterizations of nanoparticles for biomedical applications. While going deeper into my nanoparticles skills I learned new knowledge on toxicities and biological behaviors of nanohybrids made for medical purposes.

During my postdoctoral experiences from 2011 to 2016, in particular at EPFL, I continued working on synthesis and characterizations methods « GMP-like » for nanomaterials in order to answer pharmaceutical and medical requirements. I also focused my research on the study and the understanding of the role of nanoobjects physico-chemistry on the living world especially their interactions with protein from biological media: the « Protein Corona »

This thematic is driving my actual research at ICB Laboratory.

More details

2007-2010: After a chemical engineering diploma from the University of Technology of Compiegne (UTC), I started a PhD in physical chemistry at the ICB Laboratory on the Elaboration of functionalized nanoparticles: applications as MRI contrast agent. My research was focused on the syntheses of magnetic nanparticles via soft chemistry or hydrothermal and continuous methods with an accurate control of the physicochemical properties and in depth characterizations. Nanoparticles’ surfaces were also modified and functionalized for a better biocompatibility, less toxicity and targeting behviors in order to be used as a Magnetic Resonance Imaging (MRI) contrast agent.

2011-2015: I worked for 4 years in Pr. H. Hofmann’s team at the Ecole Polytechnique Fédérale de Lausanne (EPFL) on a FP7 European project (Nanodiara) on the development of novel nanotechnology based diagnostic and therapeutic systems for arthritic diseases. My research was centered on one part on the reproducibility and scale-up of the syntheses and methods to face biomedical challenges. On another part, I studied the interactions between nanoparticles and proteins in order to better understand their biological behaviors. This scientific area is commonly called: the « Protein Corona« .

2015-2016: After these projects, I continued my research at Dublin City University (Pr. Dermot Brougham) on a FP7 European project (UNION). Then at Basel University (Pr. Cornelia Palivan) I worked on a Swiss project NCCR (National Centres of Competence in Research). These two projects were focused on the development of physicochemical solutions for biomedical applications such as  « nano-flowers » or « nano-vesicles ».

Since the end of 2016: I got a CNRS Researcher (CR) permanent position at Pr. Nadine Millot’s team from the nanosciences department of the ICB laboratory to continue working on my thematic focused on  the development of nanomedical solutions and on the understanding of their biological behaviors.

Main fields of expertise

  • Control of physico-chemistry of nanomaterials

More details

Synthesis of inorganic nanoparticles such as iron oxide (SPIONs), titanate nanotubes (TiONTs), gold or polymeric vesicles (polymersomes).

Control of the size, the oxidation state, the composition and the morphology of nanoparticles.

Development of reproducible and up-scalable methods for nanomaterials.

  • « GMP-like » surface modification of nanomaterials for biomedical purposes

More details

  • Surface modification of nanoparticles for better biocompatibility (polymer, core/shell structures, organic molecules…).

    Functionalization of nanohybrids with targeting molecules for bimodal detections.

    Reproducible methods compatible with in vitro and in vivo applications especially pharmacokinetic studies.

  • Biological interactions of nanomaterials

More details

Studies of biological behaviors of nanoparticles such as cytotoxicity, cellular interactions and biodistribution.

Development of innovative analysis methods of nanohybrids for biological studies.

Understanding of the role of physico-chemistry in the interactions nanoparticles / proteins: Protein Corona.

Projects in progress

  • Regional project on the studies and understanding of proteins interactions with NPs’ surfaces

Role during the project:

Project leader.

Main projects completed
 
In 2016 at Basel University: Swiss project NCCR (National Centers of Competence in Research) Molecular Systems Engineering on the development of innovative molecular systems approaching the complexity of a cell.

More details

Description du projet:

Project description:

This NCCR project was pooling multidisciplinary areas from the physics and chemistry to the biology, the biostatistics and the computer sciences.

The main objctive of the « Molecular Systems Engineering » project was to create complex molecular layouts to mimic cellular reactions. Such systems can be use as organic molecules (enzymes for example) industrial productions or to control cellular systemps for applications in health.

The Molecular Systems Egineering project was divided into 4 Work Packages (more details).

  • WP 1: Molecular modules
  • WP 2: Molecular systems
  • WP 3: Molecular factories
  • WP 4: Cellular systems

Role during the project:

As a scientist in the WP 2 of University of Basel, my role was to develop stimulo-sensitive membranes made from the assembly of polymeric vesicles (polymersomes) and inorganic nanoparticles functionalized with DNA. These membranes shoul induce cascade reactions between the vesicles and catalyzed by the chosen nanoparticles (more details).

From 2011 to 2014 at EPFL: FP7 European project (Nanodiara) on the development of nanotechnological tools for the detection and the therapy of arthrtic diseases.

More details

Project description:

Although treatment of rheumatoid arthritis (RA) has improved in the last years, there is still no disease modifying treatment for osteoarthritis (OA). For treatments to be effective it is considered extremely important to detect and treat these diseases early and then be able to monitor treatment efficacy early on (within weeks or months) after its initiation rather than waiting up to a year for RA and 18 months for OA. RA is a chronic inflammatory joint disease that involves acute and chronic synovial (joint lining) inflammation causing the erosive destruction of articular cartilages, ligaments and subchondral bone. It develops in about 1% of the population. OA, currently the main cause of disability among the middle age and elderly populations, is a degenerative arthritis involving much less synovial inflammation in most patients, with a prevalence of about 12% of the population.

The main objective of the NanoDiaRA project is the development of nanotechnology-based diagnostic tools for easy and early detection of disease onset, progression and responses to therapy RA and OA via specific targeting of inflammatory areas and imaging with Magnetic Resonance Imaging (MRI).  New blood and urine nanotechnology-based diagnostic biomarker assays was also developed to be a very sensitive, easy to use and affordable immunoassay benchtop analytical systems for widespread clinical use. In view of the development of this targeted nanoparticle-based technology there are also opportunities to use this tissue-targeted approach for locally controlled drug release (e.g. in joints alone/intra-articular). This way of improving drug delivery to minimize possible side effects is a long term future approach which will be examined for its feasibility during the term of the project. The overall project follows a personalized medicine approach and is driven by the prominent unmet clinical needs outlined above.

Nanodiara pooled 15 European partners from academic and industrial fields:

  1. Coordinator: Europäische Akademie GmbH, Bad Neuenahr-Ahrweiler, Germany
  2. Scientific coordinator: MatSearch Consulting Hofmann, Lausanne, Switzerland
  3. Charité Universitätsmedizin (team 1 et team 2), Berlin, Germany
  4. EPFL, Lausanne, Switzerland
  5. University of Lund, Sweden
  6. Merck® Serono, Darmastadt, Germany
  7. AnaMar AB, Lund, Sweden
  8. Arrayon Biotechnology, Neuchâtel, Switzerland
  9. CSEM SA, Neuchâtel, Switzerland
  10. Merck Estapor/OEM-Diagnostic/Merck-Millipore, Pithiviers, France
  11. PMU Salzburg, Austria
  12. University of Fribourg, Switzerland
  13. University of Geneva, Switzerland
  14. University of Nijmegen, Netherlands
  15. University of Tartu, Estonia

The NanoDiaRA project is divided into five research work packages and four supporting work packages. While the research packages deal with fundamental research, the latter are particularly addressing dissemination, publication and valorization of the research outcome, investigation of the ethical issues, training of young investigators and the administration of the project.

WP 1: Particle coating and functionalisation and novel equipment for coating and separation
WP 2: Inflammation and tissue damage detection by cell and tissue tracking and molecular MRI based imaging
WP 3a: New Biomarker/ligand and antibody detection and development: targets, antibodies and peptides
WP 3b: New Biomarker/ligand and antibody detection and development: Clinical relevance
WP 4: Development of bioassays
WP 7: Toxicity

WP 5: Scientific Coordination and Data Management
WP 6: Ethical, Legal, and Social Aspects, Technology Assessment (ELSI)
WP 8: Dissemination of Results and Foreground, Communication, Education & Training
WP 9: Management

Role during the project:

As a scientist and WP leader at EPFL, my role was pivotal and consisted in bringing nanotechnological solutions to our biological, industrial and medical partners. As main responsibles of the WP 1, we worked in close collaborations with all the scientific WP to develop specific nanoparticles for arthritic pathologies with industrial requirements such as biocompatibility and upscalable methods to have enough quantity of materials for pharmacokinetic studies. We also studied in depth the biological behaviors of our nanohybrids (toxicity, internalization, biodistribution or Protein Corona).

Special issue « Applications of nanoparticles in Pharmaceuticals »

Deadline for manuscript submissions: 31 December 2020

32 articles in peer-reviewed journals

3 international conferences proceedings

2 Book chapters

ORCID number: 0000-0002-6346-7623
Google scholar ; Publons: E-3606-2016 and Scopus: 40262179400 accounts

Most significant recent publications

    1. Protein Corona Composition of Superparamagnetic Iron Oxide Nanoparticles with Various Physico-Chemical Properties and Coatings, Scientific Reports, 4, 5020, 2014 (DOI: 10.1038/srep05020)
    2. Ex situ evaluation of the composition of protein corona of intravenously injected superparamagnetic nanoparticles in rats, Nanoscale, 6, (19), 11439-11450, 2014 (DOI: 10.1039/C4NR02793K)
    3. Influence of surface charge and polymer coating on internalization and biodistribution of PEG-modified iron oxide nanoparticles, J. Biomed. Nanotech., 11, (1), 126-136, 2015 (DOI: 10.1166/jbn.2015.1996)
    4. Significance of surface charge and shell material of Super-paramagnetic Iron Oxide Nanoparticles (SPIONs) based core/shell nanoparticles on the composition of the protein corona, Biomater. Sci., 3, (2), 265-278, 2015 (DOI: 10.1039/C4BM00264D)
    5. Beyond unpredictability: the importance of reproducibility in understanding the protein corona of nanoparticles, Bioconj. Chem., 29, (10), 3385-3393, 2018 (DOI: 10.1021/acs.bioconjchem.8b00554)
    6. Innovative Magnetic Nanoparticles for PET/MRI Bimodal Imaging, ACS Omega, 4, (2), 2637-2648, 2019 (DOI: 10.1021/acsomega.8b03283)

Publications list

Efficient Quantification by X-ray Photoelectron Spectroscopy and Thermogravimetric Analyses of the One-Pot Grafting of Two Molecules on the Surface of Iron Oxide Nanoparticles

Lionel Maurizi, Fadoua Sallem, Julien Boudon, Olivier Heintz, Harender Bisht, Frederic Bouyer, Nadine Millot,
Journal : J. Nanosci. Nanotechnol. - n° 19 - 2019 - 4920-4929

Elaboration of Trans-Resveratrol Derivative-Loaded Superparamagnetic Iron Oxide Nanoparticles for Glioma Treatment

Fadoua Sallem, Rihab Haji, Dominique Vervandier-Fasseur, Thomas Nury, Lionel Maurizi, Julien Boudon, Gerard Lizard, Nadine Millot,
Journal : Nanomaterials - n° 9 - 2019 - 287

Innovative Magnetic Nanoparticles for PET/MRI Bimodal Imaging

Guillaume Thomas, Julien Boudon, Lionel Maurizi, Mathieu Moreau, Paul Walker, Isabelle Severin, Alexandra Oudot, Christine Goze, Sophie Poty, Jean-Marc Vrigneaud, Frederic Demoisson, Franck Denat, Francois Brunotte, Nadine Millot,
Journal : ACS Omega - n° 4 - 2019 - 2637-2648

Nanoscience-Based Strategies to Engineer Antimicrobial Surfaces

Serena Rigo, Chao Cai, Gesine Gunkel-Grabole, Lionel Maurizi, Xiaoyan Zhang, Jian Xu, Cornelia G. Palivan,
Journal : Adv. Sci. - n° 5 - 2018 - 1700892

In vitro interaction and biocompatibility of titanate nanotubes with microglial cells

S. Sruthi, A. Loiseau, J. Boudon, F. Sallem, L. Maurizi, P. V. Mohanan, G. Lizard, N. Millot,
Journal : Toxicol. Appl. Pharmacol. - n° 353 - 2018 - 74-86

Characterization of liposome-containing SPIONs conjugated with anti-CD20 developed as a novel theranostic agent for central nervous system lymphoma

S. Saesoo, S. Sathornsumetee, P. Anekwiang, C. Treetidnipa, P. Thuwajit, S. Bunthot, W. Maneeprakorn, L. Maurizi, H. Hofmann, Ruktanonchai Uracha Rungsardthong, N. Saengkrit,
Journal : Colloid Surf. B-Biointerfaces - n° 161 - 2018 - 497-507

Cellular interactions of functionalized superparamagnetic iron oxide nanoparticles on oligodendrocytes without detrimental side effects: Cell death induction, oxidative stress and inflammation

S. Sruthi, L. Maurizi, T. Nury, F. Sallem, J. Boudon, J. M. Riedinger, N. Millot, F. Bouyer, G. Lizard,
Journal : Colloid Surf. B-Biointerfaces - n° 170 - 2018 - 454-462

Beyond Unpredictability: The Importance of Reproducibility in Understanding the Protein Corona of Nanoparticles

Sandra Galmarini, Usawadee Hanusch, Manon Giraud, Noelie Cayla, Diego Chiappe, Nadia von Moos, Heinrich Hofmann, Lionel Maurizi,
Journal : Bioconjugate Chem. - n° 29 - 2018 - 3385-3393

Effectiveness of hand washing on the removal of iron oxide nanoparticles from human skin ex vivo

Nastassja A. Lewinski, Aurelie Berthet, Lionel Maurizi, Antoine Eisenbeis, Nancy B. Hopf,
Journal : J. Occup. Environ. Hyg. - n° 14 - 2017 -

Superparamagnetic nanohybrids with cross-linked polymers providing higher in vitro stability

Weerakanya Maneeprakorn, Lionel Maurizi, Hathainan Siriket, Tuksadon Wutikhun, Tararaj Dharakul, Heinrich Hofmann,
Journal : J. Mater. Sci. - n° 52 - 2017 - 9249-9261

Modification of the surface of superparamagnetic iron oxide nanoparticles to enable their safe application in humans

Cindy Strehl, Lionel Maurizi, Timo Gaber, Paula Hoff, Thomas Broschard, A. Robin Poole, Heinrich Hofmann, Frank Buttgereit,
Journal : Int. J. Nanomed. - n° 11 - 2016 - 5883-5896

Effects of PVA-coated nanoparticles on human T helper cell activity

Cindy Strehl, Saskia Schellmann, Lionel Maurizi, Margarethe Hofmann-Amtenbrink, Thomas Haeupl, Heinrich Hofmann, Frank Buttgereit, Timo Gaber,
Journal : Toxicol. Lett. - n° 245 - 2016 - 52-58

NANOPARTICLES AS MRI CONTRAST AGENT FOR EARLY DIAGNOSIS OF RA: EFFECTS OF AMINO-PVA-COATED SPIONS ON CD4+T CELL ACTIVITY

C. Strehl, L. Maurizi, S. Hermann, T. Haeupl, H. Hofmann, F. Buttgereit, T. Gaber,
Journal : Ann. Rheum. Dis. - n° 75 - 2016 - 901-901

Pro-oxidant effects of nano-TiO2 on Chlamydomonas reinhardtii during short-term exposure

Nadia von Moos, Volodymyr B. Koman, Christian Santschi, Olivier J. F. Martin, Lionel Maurizi, Amarnath Jayaprakash, Paul Bowen, Vera I. Slaveykova,
Journal : RSC Adv. - n° 6 - 2016 - 115271-115283

Bidirectional Transfer Study of Polystyrene Nanoparticles across the Placental Barrier in an ex Vivo Human Placental Perfusion Model

Stefanie Grafmueller, Pius Manser, Liliane Diener, Pierre-Andre Diener, Xenia Maeder-Althaus, Lionel Maurizi, Wolfram Jochum, Harald F. Krug, Tina Buerki-Thurnherr, Ursula von Mandach, Peter Wick,
Journal : Environ. Health Perspect. - n° 123 - 2015 - 1280-1286

Transfer studies of polystyrene nanoparticles in the ex vivo human placenta perfusion model: key sources of artifacts

Stefanie Grafmueller, Pius Manser, Liliane Diener, Lionel Maurizi, Pierre-Andre Diener, Heinrich Hofmann, Wolfram Jochum, Harald F. Krug, Tina Buerki-Thurnherr, Ursula von Mandach, Peter Wick,
Journal : Sci. Technol. Adv. Mater. - n° 16 - 2015 - 044602

The In-Vivo Use of Superparamagnetic Iron Oxide Nanoparticles to Detect Inflammation Elicits a Cytokine Response but Does Not Aggravate Experimental Arthritis

Eline A. Vermeij, Marije I. Koenders, Miranda B. Bennink, Lindsey A. Crowe, Lionel Maurizi, Jean-Paul Vallee, Heinrich Hofmann, Wim B. van den Berg, Peter L. E. M. van Lent, Fons A. J. van de Loo,
Journal : PLoS One - n° 10 - 2015 -

Effects of PVA coated nanoparticles on human immune cells

Cindy Strehl, Timo Gaber, Lionel Maurizi, Martin Hahne, Roman Rauch, Paula Hoff, Thomas Haeupl, Margarethe Hofmann-Amterbrink, A. Robin Poole, Heinrich Hofmann, Frank Buttgereit,
Journal : Int. J. Nanomed. - n° 10 - 2015 - 3429-3445

Significance of surface charge and shell material of superparamagnetic iron oxide nanoparticle (SPION) based core/shell nanoparticles on the composition of the protein corona

Usawadee Sakulkhu, Morteza Mahmoudi, Lionel Maurizi, Geraldine Coullerez, Margarethe Hofmann-Amtenbrink, Marcel Vries, Mahdi Motazacker, Farhad Rezaee, Heinrich Hofmann,
Journal : Biomater. Sci. - n° 3 - 2015 - 265-278

Polymer Adsorption on Iron Oxide Nanoparticles for One-Step Amino-Functionalized Silica Encapsulation

Lionel Maurizi, Alexis Claveau, Heinrich Hofmann,
Journal : J. Nanomater. - n° - 2015 - 732719

Influence of Surface Charge and Polymer Coating on Internalization and Biodistribution of Polyethylene Glycol-Modified Iron Oxide Nanoparticles

Lionel Maurizi, Anne-Laure Papa, Laure Dumont, Frederic Bouyer, Paul Walker, David Vandroux, Nadine Millot,
Journal : J. Biomed. Nanotechnol. - n° 11 - 2015 - 126-136

Ex situ evaluation of the composition of protein corona of intravenously injected superparamagnetic nanoparticles in rats

Usawadee Sakulkhu, Lionel Maurizi, Morteza Mahmoudi, Mahdi Motazacker, Marcel Vries, Azza Gramoun, Marie-Gabrielle Ollivier Beuzelin, Jean-Paul Vallee, Farhad Rezaee, Heinrich Hofmann,
Journal : Nanoscale - n° 6 - 2014 - 11439-11450

Aqueous stabilisation of carbon-encapsulated superparamagnetic alpha-iron nanoparticles for biomedical applications

Noemi Aguilo-Aguayo, Lionel Maurizi, Sandra Galmarini, Marie Gabrielle Ollivier-Beuzelin, Geraldine Coullerez, Enric Bertran, Heinrich Hofmann,
Journal : Dalton Trans. - n° 43 - 2014 - 13764-13775

Monitoring the effects of dexamethasone treatment by MRI using in vivo iron oxide nanoparticle-labeled macrophages

Azza Gramoun, Lindsey A. Crowe, Lionel Maurizi, Wolfgang Wirth, Frank Tobalem, Kerstin Grosdemange, Geraldine Coullerez, Felix Eckstein, Marije I. Koenders, Wim B. Van den Berg, Heinrich Hofmann, Jean-Paul Vallee,
Journal : Arthritis Res. Ther. - n° 16 - 2014 -

Amino-polyvinyl Alcohol Coated Superparamagnetic Iron Oxide Nanoparticles are Suitable for Monitoring of Human Mesenchymal Stromal Cells In Vivo

Frank Schulze, Anke Dienelt, Sven Geissler, Paul Zaslansky, Janosch Schoon, Katja Henzler, Peter Guttmann, Azza Gramoun, Lindsey A. Crowe, Lionel Maurizi, Jean-Paul Vallee, Heinrich Hofmann, Georg N. Duda, Andrea Ode,
Journal : Small - n° 10 - 2014 - 4340-4351

IMPACT OF AMINO-PVA COATED NANOPARTICLES ON VIABILITY AND CYTOKINE SECRETION OF HUMAN IMMUNE CELLS OBTAINED FROM HEALTHY DONORS AND PATIENTS WITH RHEUMATOID ARTHRITIS

C. Strehl, T. Gaber, M. Jakstadt, M. Hahne, P. Hoff, L. Maurizi, H. Hofmann, G. -R. Burmester, F. Buttgereit,
Journal : Ann. Rheum. Dis. - n° 73 - 2014 - 219-219

Protein Corona Composition of Superparamagnetic Iron Oxide Nanoparticles with Various Physico-Chemical Properties and Coatings

Usawadee Sakulkhu, Morteza Mahmoudi, Lionel Maurizi, Jatuporn Salaklang, Heinrich Hofmann,
Journal : Sci Rep - n° 4 - 2014 - 5020

A fast and reproducible method to quantify magnetic nanoparticle biodistribution

Lionel Maurizi, Usawadee Sakulkhu, Azza Gramoun, Jean-Paul Vallee, Heinrich Hofmann,
Journal : Analyst - n° 139 - 2014 - 1184-1191

Syntheses of cross-linked polymeric superparamagnetic beads with tunable properties

Lionel Maurizi, Usawadee Sakulkhu, Lindsey A. Crowe, Vanessa Mai Dao, Nicolas Leclaire, Jean-Paul Vallee, Heinrich Hofmann,
Journal : RSC Adv. - n° 4 - 2014 - 11142-11146

Fast and continuous synthesis of nanostructured iron spinel in supercritical water: influence of cations and citrates

L. Maurizi, F. Bouyer, M. Ariane, R. Chassagnon, N. Millot,
Journal : RSC Adv. - n° 4 - 2014 - 45673-45678

Visible light optical coherence correlation spectroscopy

Stephane Broillet, Daniel Szlag, Arno Bouwens, Lionel Maurizi, Heinrich Hofmann, Theo Lasser, Marcel Leutenegger,
Journal : Opt. Express - n° 22 - 2014 - 21944-21957

One step continuous hydrothermal synthesis of very fine stabilized superparamagnetic nanoparticles of magnetite

Lionel Maurizi, Frederic Bouyer, Jeremy Paris, Frederic Demoisson, Lucien Saviot, Nadine Millot,
Journal : Chem. Commun. - n° 47 - 2011 - 11706-11708

Synthesis of Titanate Nanotubes Directly Coated with USPIO in Hydrothermal Conditions: A New Detectable Nanocarrier

Anne-Laure Papa, Lionel Maurizi, David Vandroux, Paul Walker, Nadine Millot,
Journal : J. Phys. Chem. C - n° 115 - 2011 - 19012-19017

Easy Route to Functionalize Iron Oxide Nanoparticles via Long-Term Stable Thiol Groups

L. Maurizi, H. Bisht, F. Bouyer, N. Millot,
Journal : Langmuir - n° 25 - 2009 - 8857-8859

Books chapters

Nanoparticles in the Lung:
Environmental Exposure and Drug Delivery
Edited by Akira Tsuda and Peter Gehr

Section VI:Special Issues
Chapter 16: Physicochemical, Colloidal, and Transport Properties
(pages 251-266)

Heinrich Hofmann, Lionel Maurizi, Marie-Gabrielle Beuzelin, Usawadee Sakulkhu and Vianney Bernau

December 19, 2014 by CRC Press – 403 Pages
ISBN 9781439892794 – CAT# K14165

Unraveling the Safety Profile of Nanoscale Particles and Materials –
From Biomedical to Environmental Applications
Edited by Andreia C. Gomes and Marisa P. Sarria

Chapter 2
Toxicological Risk Assessment of Emerging Nanomaterials: Cytotoxicity, Cellular Uptake, Effects on Biogenesis and Cell Organelle Activity, Acute Toxicity and Biodistribution of Oxide Nanoparticles
(pages 17-36)

Lionel Maurizi, Anne-Laure Papa, Julien Boudon, Sruthi Sudhakaran, Benoit Pruvost, David Vandroux, Johanna Chluba, Gerard Lizard and Nadine Millot

March, 2018 by InTech – 172 Pages
ISBN 9789535139409

49 international and national conferences including:

7 invited talks with international collaborators

Organizer of the ANF NanoMed 2018 (Summer school on Nanomedicine in 2018)

Principal investigator of the event A Class a Researcher in 2018-2019 and 2019-2020 when school children meet researchers (visit to schools and visit in the labs with experiments)

Teaching:

36 hours per year on supervised project: Fifth year of engineering school: ESIREM (École supérieure d’ingénieurs de recherche en matériaux et en infotronique)

Supervisions:

  • 4 PhD students (1 in progress)
  • 7 Master theses
  • 18 students from Bachelor to Master (3 in progress)

statut_ub:
batiment:
equipe_1:
OCS
fonction_equipe_1:
Agent(e) de service
mots_cles:
adresse:
onglets:
{tab=Carrière} # {tab=Projets} # {tab=Publications} # {tab=Communications} # {tab=Enseignements} # {tab=Administration} # {/tabs}
telephone:
+333 80 39 61 71
e-mail:
lionel.maurizi@u-bourgogne.fr
site_web:
departement:
a:1:{i:0;s:12:"Nanosciences";}
fonction:
CR CNRS
localisation:
C408A
texte_onglets:
carriere:
projets:
communications:
publications:
enseignements:
administration:
kc_data:
a:8:{i:0;s:0:"";s:4:"mode";s:2:"kc";s:3:"css";s:0:"";s:9:"max_width";s:0:"";s:7:"classes";s:0:"";s:9:"thumbnail";s:0:"";s:9:"collapsed";s:0:"";s:9:"optimized";s:0:"";}
switch:
1
kc_raw_content:

Log In

Create an account